Drug therapies in chronic heart failure: a focus on reduced ejection fraction
Helena Bolam, Geraint Morton and Paul R Kalra
DOI: https://doi.org/10.7861/clinmedicine.18-2-138
Clin Med April 2018 Helena Bolam
ADepartment of Cardiology, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust, Portsmouth, UK
Roles: cardiology specialist registrar
Geraint Morton
BDepartment of Cardiology, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust, Portsmouth, UK
Roles: consultant cardiologist
Paul R Kalra
CDepartment of Cardiology, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust, Portsmouth, UK
Roles: consultant cardiologist
Article Tools
Drug therapies in chronic heart failure: a focus on reduced ejection fraction
Helena Bolam, Geraint Morton, Paul R Kalra
Clinical Medicine Apr 2018, 18 (2) 138-145; DOI: 10.7861/clinmedicine.18-2-138
Citation Manager Formats
Jump to section
- Article
- ABSTRACT
- Introduction
- Established prognostic therapy in HFrEF
- Newer agents with prognostic benefit
- Diuretics
- Older therapies with some prognostic benefit
- Drugs with little or no prognostic benefit
- Considerations in specific situations
- Systems of care for optimising drug therapy
- The future
- Drug therapies in HFpEF/HFmrEF
- Drug therapies in the prevention of heart failure
- Conclusion
- Conflicts of interest
- References
- Figures & Data
- Info & Metrics
Related Articles
- No related articles found.